NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/23/2025
Back to search
Official data from USPTO
F FIERCE PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
12/23/2025
Trademark type
Combined
Nice classes
35, 41, 42
Filing date
12/26/2024
Registration date
12/23/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/23/2025
Last transaction
12/23/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
06/05/2020
First use in commerce
06/05/2020
Drawing code
3
Owner type
16
Owner location
New York, NY
Examiner
BERGER, MAGDALENA
Law office
N50
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a stylized "F" design next to the wording "FIERCE PHARMA".
Holders and representatives
Holders
Questex, LLC
Representatives
Deborah J. Peckham Barclay Damon LLP
Technical classification
Nice Classes
Class 35Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Conductingarrangingpromoting and organizing trade showsbusiness expos and buyer events for business purposes in the fields of pharmaceuticalsdrug policydrug developmentcell and gene therapydrug manufacturing and drug regulations; providing public policy information in the field of drugs
Class 41
Arranging and conducting in-person educational forumseducational meetingsconferencesconventions in the fields of pharmaceuticalsdrug policydrug developmentcell and gene therapydrug manufacturing and drug regulations; educational servicesarranging and conducting educational conferencesseminars and workshops in the fields of pharmaceuticalsdrug policydrug developmentcell and gene therapydrug manufacturing and drug regulations; providing information and news in the fields of pharmaceuticalsdrug policydrug developmentcell and gene therapydrug manufacturing and drug regulations; providing onlinenon-downloadable newsletters in the fields of pharmaceuticalsdrug developmentcell and gene therapydrug manufacturing and drug regulations; conducting of business conferences in the field of pharmaceuticalsdrug policydrug developmentcell and gene therapydrug manufacturing and drug regulations
Class 42
Providing medical and scientific research information and news in the fields of pharmaceuticalsdrug developmentcell and gene therapydrug manufacturing
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/23/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/04/2025
PUBO
PUBLISHED FOR OPPOSITION
11/04/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/29/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/01/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
09/22/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/22/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
09/22/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/22/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/11/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/11/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/11/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/11/2025
GNRT
NON-FINAL ACTION E-MAILED
06/11/2025
CNRT
NON-FINAL ACTION WRITTEN
06/11/2025
DOCK
ASSIGNED TO EXAMINER
06/05/2025
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/27/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/27/2025
NWAP
NEW APPLICATION ENTERED
12/26/2024
Continuous trademark protection
Get notified about every new filing that threatens F FIERCE PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.